Korea Investment Corp
TEVA icon

Korea Investment Corp’s Teva Pharmaceuticals TEVA Stock Holding History

Korea Investment Corp’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.4M Sell
453,579
-35,666
-7% -$1.19M 0.03% 421
2026
Q1 		$14.7M Buy
489,245
+40,149
+9% +$1.29M 0.03% 433
2025
Q4 		$14M Buy
449,096
+69,541
+18% +$1.71M 0.03% 440
2025
Q3 		$7.67M Buy
379,555
+5,100
+1% +$89.6K 0.02% 533
2025
Q2 		$6.28M Buy
374,455
+3,000
+0.8% +$48.4K 0.01% 576
2025
Q1 		$5.71M Sell
371,455
-10,500
-3% -$188K 0.01% 603
2024
Q4 		$8.42M Buy
381,955
+159,899
+72% +$2.91M 0.02% 551
2024
Q3 		$4M Buy
222,056
+1,300
+0.6% +$22.8K 0.01% 611
2024
Q2 		$3.59M Sell
220,756
-3,700
-2% -$57K 0.01% 620
2024
Q1 		$3.17M Buy
224,456
+1,097
+0.5% +$13.8K 0.01% 650
2023
Q4 		$2.33M Buy
223,359
+25,976
+13% +$243K 0.01% 674
2023
Q3 		$2.01M Sell
197,383
-33,010
-14% -$307K 0.01% 664
2023
Q2 		$1.73M Buy
230,393
+19,400
+9% +$157K ﹤0.01% 679
2023
Q1 		$1.87M Sell
210,993
-51,385
-20% -$508K 0.01% 676
2022
Q4 		$2.39M Sell
262,378
-4,684
-2% -$40.9K 0.01% 669
2022
Q3 		$2.15M Buy
267,062
+78,962
+42% +$698K 0.01% 667
2022
Q2 		$1.42M Buy
188,100
+6,800
+4% +$59.2K ﹤0.01% 698
2022
Q1 		$1.7M Buy
181,300
+48,200
+36% +$402K ﹤0.01% 676
2021
Q4 		$1.07M Buy
133,100
+12,900
+11% +$116K ﹤0.01% 695
2021
Q3 		$1.17M Sell
120,200
-5,300
-4% -$49.6K ﹤0.01% 698
2021
Q2 		$1.24M Buy
125,500
+19,700
+19% +$209K ﹤0.01% 708
2021
Q1 		$1.22M Sell
105,800
-342,855
-76% -$3.93M ﹤0.01% 686
2020
Q4 		$4.33M Sell
448,655
-51,200
-10% -$490K 0.01% 533
2020
Q3 		$4.5M Sell
499,855
-900
-0.2% -$9.52K 0.02% 448
2020
Q2 		$6.17M Sell
500,755
-135,200
-21% -$1.53M 0.02% 403
2020
Q1 		$5.71M Buy
635,955
+124,500
+24% +$1.28M 0.03% 382
2019
Q4 		$5.01M Buy
511,455
+29,400
+6% +$262K 0.02% 463
2019
Q3 		$3.32M Buy
482,055
+9,000
+2% +$69K 0.01% 488
2019
Q2 		$4.37M Sell
473,055
-127,600
-21% -$1.54M 0.02% 460
2019
Q1 		$9.42M Buy
600,655
+24,000
+4% +$423K 0.04% 372
2018
Q4 		$8.89M Sell
576,655
-28,978
-5% -$594K 0.05% 343
2018
Q3 		$13M Buy
605,633
+52,600
+10% +$1.22M 0.06% 295
2018
Q2 		$13.4M Buy
553,033
+119,900
+28% +$2.45M 0.06% 290
2018
Q1 		$7.4M Buy
433,133
+183,300
+73% +$3.58M 0.03% 392
2017
Q4 		$4.73M Buy
249,833
+5,059
+2% +$76.1K 0.02% 477
2017
Q3 		$4.31M Buy
244,774
+30,674
+14% +$690K 0.02% 477
2017
Q2 		$7.11M Buy
+214,100
New +$6.63M 0.03% 388
2013
Q3 		– Sell
-451,500
Closed -$17.7M – 589
2013
Q2 		$17.7M Buy
+451,500
New +$17.6M 0.21% 105

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Korea Investment Corp's TEVA Position: Q2 2026 in Review

Korea Investment Corp reduced its Teva Pharmaceuticals (TEVA) stake by 7.3% in Q2 2026, selling an estimated $1.19M and leaving 453,579 shares worth $15.4M. The position accounts for 0.03% of the portfolio, ranked #421.

Korea Investment Corp first reported a position in TEVA in Q2 2013 and has held it in 38 quarters since. The position peaked at $17.7M in Q2 2013. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Korea Investment Corp held 453,579 shares of Teva Pharmaceuticals worth $15.4M as of Q2 2026.
  • Korea Investment Corp sold 35,666 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.19M.
  • Teva Pharmaceuticals made up 0.03% of Korea Investment Corp's portfolio in Q2 2026, its #421 holding.
  • Korea Investment Corp first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 38 quarters since.
  • Korea Investment Corp's Teva Pharmaceuticals position peaked at $17.7M in Q2 2013.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Korea Investment Corp's 13F filing for Q2 2026, filed 12 Aug 2026.